On April 21, 2016, CHA Biotech Co., Ltd. closed the transaction. The fifth series bonds included participation from new investors Kiwoom Securities Co., Ltd., Investment Arm for KRW 9,000,000,000, SBI Savings Bank Inc., Investment Arm for KRW 4,000,000,000, Anda Cruise Private Investment Fund No. 1 for KRW 4,000,000,000, GMB Investment Co., Ltd. for KRW 2,000,000,000, and IBK Capital Corporation for KRW 1,000,000,000.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17,100 KRW | +0.88% | +1.79% | -12.71% |
01-08 | CHA Biotech to Partner with Subsidiary to Advance NK Cell Therapy | MT |
2023 | CHA Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-12.71% | 712M | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B | |
-6.26% | 11.42B |
- Stock Market
- Equities
- A085660 Stock
- News Chabiotech Co.,Ltd.
- CHA Biotech Co., Ltd. announced that it has received KRW 44 billion in funding from a group of investors